Compound 511
Identifiers
- Canonical SMILES:
CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)C(=O)OC)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F
- IUPAC name:
methyl 1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidine-4-carboxylate
- InChi:
InChI=1S/C32H30Cl2F3N3O4/c1-3-44-26-18-22(32(35,36)37)8-13-25(26)29-38-27(19-4-9-23(33)10-5-19)28(20-6-11-24(34)12-7-20)40(29)31(42)39-16-14-21(15-17-39)30(41)43-2/h4-13,18,21,27-28H,3,14-17H2,1-2H3/t27-,28-/m0/s1
- InChiKey:
OCJNCKPZMYMQPW-NSOVKSMOSA-N
External links
168318194 |
9333144 |
External search
Bibliography (1)
Publication | Name |
---|---|
Gregory Jay Haley, Norman Kong, Emily Aijun Liu, Klaus B. Simonsen, Binh Thanh Vu, Stephen Evan Webber, F. Hoffmann-La Roche Ag. . Cis-2,4,5-triaryl-imidazolines None. | 16 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.76 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 647.16 g/mol | |||
HBA | 7 | |||
HBD | 0 | |||
HBA + HBD | 7 | |||
AlogP | 7.29 | |||
TPSA | 71.44 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2005003097 | 16 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 5.76 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8028 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.7812 | RO-5045337 | DB14793 | |
0.7156 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.4244 | Sorbinil | DB02712 | |
0.4124 | Fidarestat | DB02021 | |
0.4124 | (S,R)-fidarestat | DB02101 | |
0.3904 | (6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one | DB07874 | |
0.3851 | PCO-371 | DB14946 | |
0.3846 | Idanpramine | DB13276 | |
0.3831 | Irbesartan | DB01029 | |
0.3783 | [N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine | DB03081 | |
0.3782 | Atrasentan | DB06199 | |
0.3750 | Atecegatran metoxil | DB12507 | |
0.3730 | CC-220 | DB12101 | |
0.3717 | AGG-523 | DB15460 |